Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1316 Views
Dr Abir Saraswat, Lucknow 21 January 2019
o Rapidly progressive disease that spreads easily amongst contacts
o Unusual, highly symptomatic manifestations
o Poor response to recommend treatments
o Repeated episodes in spite of apparently successful treatment.
o There are no defined criteria for labeling dermatophyte strains sensitive or resistant
o Clinical-lab correlation for antifungal sensitivity studies remains relatively poor
o A recent expert consensus recommended terbinafine or itraconazole for the initial treatment of tinea corporis.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}